US FDA gives full approval to #Remdesivir antiviral drug to treat COVID-19 #COVID19India
@US_FDA
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
DRREDDY
5,003.15
-18.85 (-0.38%)
Updated 03:29 23/10 IST
DRREDDY Buy or Sell - FrontPage Forums
0 Users have submitted 0 trade ideas of Rs. 0 for DRREDDY
Disclaimer0% Bullish
0% Bearish
DRREDDY Buy or Sell - Brokerage Reports
No. of reports in last year
19
No. of analysts
8
Average Consensus Forecast
4283.47
Consensus Potential
-24.79%
DRREDDY Ratings
Long term DRREDDY rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
4.5/5 (11 Ratings)
Find answers to all your questions on live DRREDDY message board: Is DRREDDY buy or sell? Should I buy DRREDDY shares? Why are DRREDDY shares falling? Should I invest in DRREDDY stock?
- Home
- DRREDDY Forum
DRREDDY Share Price Discussion
N
Reputation: 7,204 • Today 2:53 AM
Coronavirus vaccine update: Dr Reddy's to test Sputnik V on 100 volunteers in phase 2
Upon regulatory approval in India, RDIF will supply 100 million doses of Sputnik V to Dr Reddy's.
Upon regulatory approval in India, RDIF will supply 100 million doses of Sputnik V to Dr Reddy's.
Moneycontrol
Like
Reply
N
Reputation: 7,204 • Today 1:18 AM
ICICI Bank shuts down operations in Sri Lanka
The Monetary Board of the Central Bank of Sri Lanka, having considered the request made by ICICI Bank, has granted approval to close down business operation of the bank in Sri Lanka and cancel the licence issued to it, ICICI Bank said in a regulatory filing.
The Monetary Board of the Central Bank of Sri Lanka, having considered the request made by ICICI Bank, has granted approval to close down business operation of the bank in Sri Lanka and cancel the licence issued to it, ICICI Bank said in a regulatory filing.
Moneycontrol
Like
Reply
N
Reputation: 7,204 • Today 1:13 AM
Unsustainable debt symptom of fundamental issues in company's business model: SBI executive
Arijit Basu, Managing Director of Commercial Clients Groups at State Bank of India (SBI), also said the Insolvency and Bankruptcy Code (IBC) has provided equal opportunity to corporate sector and banks.
Arijit Basu, Managing Director of Commercial Clients Groups at State Bank of India (SBI), also said the Insolvency and Bankruptcy Code (IBC) has provided equal opportunity to corporate sector and banks.
Moneycontrol
Like
Reply
T
Reputation: 1,846 • Today 11:36 AM
Like
Reply
S
Reputation: 256 • Today 8:20 AM
Like
Reply
A
Reputation: 16,142 • Yesterday 4:37 AM
TOWER TALK 24/10/2020
SBI Card’s Q2FY21 profit fell to Rs.206 crore from Rs.381 crore in Q2FY20. Its Q2 NPAs are much higher than the 4.3% reported given the Supreme Court restriction on reporting Covid-19 related defaults. SELL.
Umang Dairies, a part of the JK Group, posted ov...
Read more...
1
Reply
N
Reputation: 7,204 • Yesterday 4:28 AM
Tata Motors crosses 40 lakh cumulative production milestone
The company has been focussing not only on the safety aspect of its vehicles but has also been leading the electric vehicle space in the country, Tata Motors President Passenger Vehicles Business Unit (PVBU) Shailesh Chandra said.
The company has been focussing not only on the safety aspect of its vehicles but has also been leading the electric vehicle space in the country, Tata Motors President Passenger Vehicles Business Unit (PVBU) Shailesh Chandra said.
Moneycontrol
Like
Reply
T
Reputation: 25,082 • Yesterday 4:02 AM
*MONEYTIMES TALK*
SBI Card’s Q2FY21 profit fell to Rs.206 crore from Rs.381 crore in Q2FY20. Its Q2 NPAs are much higher than the 4.3% reported given the Supreme Court restriction on reporting Covid-19 related defaults. SELL.
Umang Dairies, a part of the JK Group, posted over 80%...
Read more...
1
Reply
E
Reputation: 93 • Yesterday 3:48 AM
Eagle 4 AIMTIP OF THE DAY: Don’t just trust any breakout o...
Like
Reply
T
Reputation: 1,846 • Yesterday 3:44 AM
The stock gave Fibonacci 23.6% levels after a retracement to 38.2% in 2 hours TF.
BUY ABOVE 4445
Like
Reply
B
Reputation: 294 • Yesterday 3:42 AM
we are still in the range of 12000 and 11800
a clear break of either these levels can give good move for coming months
however a sudden break of this levels are not expected it could be consolidating for coming weeks too
so trade safe !protect capital!
stay tuned for...
Read more...
1
Reply
E
Reputation: 93 • Yesterday 3:24 AM
#TATASTEEL it just made a good triangle pattern. Also just touched a good resistance level. Could give breakdown and give a profitable target for short sellers. Also may consolidate first and then fall. 😇😇😇
Like
Reply
G
Reputation: 5,813 • Yesterday 3:11 AM
#BIGBLOC MEDIUM TERM BUY MODE TGT 92/128 SL 63 ( WEEKLY CLBS)
Like
Reply
G
Reputation: 5,813 • Yesterday 3:09 AM
#REDINGTON MEDIUM TERM BUY MODE TGT 144/169 SL 120 ( WEEKLY CLBS )
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
DRREDDY Share Price - Technicals
- NewsBotToday 2:53 AMCoronavirus vaccine update: Dr Reddy's to test Sputnik V on 100 volunteers in phase 2MoneycontrolNewsBotOct 22 6:58 AM
Dr Reddy's Labs shares trade lower as data breach forces the company to shut plantsMoneycontrolNewsBotOct 22 5:53 AM
Days after Russian COVID-19 vaccine trial approval, data breach forces Dr Reddy's to shut plantsMoneycontrolNewsBotOct 22 4:58 AM
Dr Reddy's Lab shares fall 4% after firm shuts plants on reports of data breachMoneycontrolNewsBotOct 22 4:53 AM
Days after Russian COVID-19 vaccine trial approval, data breach forces Dr Reddy's to shut plants: ReportsMoneycontrolNewsBotOct 22 4:28 AM
Dr. Reddy's Laboratories shuts plants after data breach: ReportMoneycontrolNewsBotOct 20 9:58 AM
Dr Reddy's launches generic product in US to treat gastroesophageal reflux diseaseMoneycontrolNewsBotOct 18 6:03 AM
Russia's COVID-19 vaccine Sputnik V makes headway in IndiaMoneycontrolNewsBotOct 6 6:33 AM
Accumulate Dr. Reddy's Laboratories; target of Rs 5648: Prabhudas LilladherMoneycontrolNewsBotOct 6 4:03 AM
Russian COVID-19 vaccine update: Dr Reddy's told to submit revised application for phase 2, 3 clinical trials of Sputnik VMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.